Callcut Rachael A, Cripps Michael W, Nelson Mary F, Conroy Amanda S, Robinson Bryce B R, Cohen Mitchell J
From the Department of Surgery (R.A.C., M.F.N., A.S.C., M.J.C.), University of California San Francisco, San Francisco, California; Department of Surgery (M.W.C.), University of Texas-Southwestern, Dallas, Texas; Department of Surgery (B.B.R.R.), University of Cincinnati, Cincinnati, Ohio.
J Trauma Acute Care Surg. 2016 Mar;80(3):450-6. doi: 10.1097/TA.0000000000000914.
Previous work proposed a Massive Transfusion Score (MTS) calculated from values obtained in the emergency department to predict likelihood of massive transfusion (MT). We hypothesized the MTS could be used at Hour 6 to differentiate who continues to require balanced resuscitation in Hours 7 to 24 and to predict death at 28 days.
We prospectively enrolled patients in whom the MT protocol was initiated from 2005 to 2011. Data including timing of blood products were determined at Hours 0, 6, 12, and 24. For each patient, transfusion needs were defined based on either an inappropriately low hemoglobin response to transfusion or a hemoglobin decrease of greater than 1 g/dL if no transfusion. Timing and cause of death were used to account for survivor bias. Multivariate logistic regression was used to determine independent predictors of outcome.
A total of 190 MT protocol activations were included, and by Hour 6, 61% required 10 U or greater packed red blood cells. Calculated at initial presentation, a revised MTS (systolic blood pressure < 90 mm Hg, base deficit ≥ 6, temperature < 35.5°C, international normalized ratio > 1.5, hemoglobin < 11 g/dL) was superior to the original MTS (including heart rate ≥ 120 beats per minute, Focused Assessment With Sonography in Trauma [FAST] status, mechanism) or the Assessment of Blood Consumption (ABC) score for predicting MT (area under the curve [AUC] MT at 6 hours, 0.68; 95% confidence interval [CI], 0.57-0.79; at 24 hours, 0.72; 0.61-0.83; p < 0.05). For those alive at Hour 6, the revised MTS was predictive of future packed red blood cell need (AUC, 0.87) in Hours 7 to 12, 24-hour mortality (AUC, 0.95), and 28-day mortality (AUC, 0.77). For each additional positive trigger of the MTS at Hour 6, the odds of death at 24 hours and 28 days were substantially increased (24-hour odds ratio, 4.6; 95% CI, 2.3-9.3; 28-day odds ratio, 2.2; 95% CI, 1.5-3.2; p < 0.0001).
Early end points of resuscitation adopted from the components of the revised MTS are predictive of ongoing transfusion. Failure to normalize these components by Hour 6 portends a particularly poor prognosis.
Prognostic study, level 3.
先前的研究提出了一种根据急诊科所获数值计算得出的大量输血评分(MTS),用于预测大量输血(MT)的可能性。我们假设MTS可在第6小时用于区分哪些患者在第7至24小时仍需进行平衡复苏,并预测28天的死亡率。
我们前瞻性纳入了2005年至2011年启动MT方案的患者。在第0、6、12和24小时确定包括血液制品输注时间在内的数据。对于每位患者,根据对输血的血红蛋白反应过低或未输血时血红蛋白下降超过1 g/dL来定义输血需求。死亡时间和原因用于考虑幸存者偏差。采用多变量逻辑回归来确定结局的独立预测因素。
共纳入190次MT方案激活,到第6小时,61%的患者需要10单位或更多的浓缩红细胞。在初始就诊时计算得出的修订MTS(收缩压<90 mmHg、碱缺失≥6、体温<35.5°C、国际标准化比值>1.5、血红蛋白<11 g/dL)在预测MT方面优于原始MTS(包括心率≥120次/分钟、创伤超声重点评估[FAST]状态、受伤机制)或血液消耗评估(ABC)评分(6小时时MT的曲线下面积[AUC]为0.68;95%置信区间[CI],0.57 - 0.79;24小时时为0.72;0.61 - 0.83;p<0.05)。对于在第6小时存活的患者,修订后的MTS可预测第7至12小时未来浓缩红细胞的需求(AUC为0.87)、24小时死亡率(AUC为0.95)和28天死亡率(AUC为0.77)。在第6小时MTS每增加一个阳性触发因素,24小时和28天死亡的几率大幅增加(24小时优势比为4.6;95%CI,2.3 - 9.3;28天优势比为2.2;95%CI,1.5 - 3.2;p<0.0001)。
从修订后的MTS组成部分采用的早期复苏终点可预测持续输血情况。到第6小时这些指标未能恢复正常预示预后特别差。
预后研究,3级。